对于切莱科克西布重新使用的挑战和机遇
1Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna Street, 30-688, Cracow, Poland.
Pharmaceutical research
|August 8, 2023
概括
药物重新定位加速了新药的开发. 本综述探讨了选择性COX-2抑制剂塞莱科西布的新治疗点,并讨论了其在癌症,精神疾病和传染病方面的潜力.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
- 药用化学 医学化学
背景情况:
- 药物重新定位是加速新药开发的关键策略.
- 具有已知的安全性配置文件的现有药物的重新用途为发现新的治疗应用提供了一个有希望的途径.
- 选择性COX-2抑制剂塞莱科克西布已经显示出超出其最初的抗炎症指示的潜力.
研究的目的:
- 审查最近的努力,以确定新的治疗点,为celecoxib.
- 在瘤学,精神病学和传染病等领域探索塞莱科西布的扩大临床潜力.
- 讨论配方挑战和开发新药输送系统的进展.
主要方法:
- 在MEDLINE PubMed,Scopus和临床试验注册表中进行了全面的文献搜索.
- 在各种治疗环境中分析关于赛莱科克西布有效性和安全性的现有数据.
- 对药物技术的审查,以优化赛莱科克西布的配方和输送.
主要成果:
- 鉴定除抗炎作用外,切莱科西布的新兴治疗应用.
- 讨论塞莱科西布在计量学癌症治疗,精神障碍和传染病方面的潜力.
- 包括纳米载体,微粒子和基于脂质的系统在内的配方策略的概述,以应对物理化学挑战.
结论:
- 塞莱科克西布显示出重新定位到新的治疗领域的巨大潜力.
- 克服配方和交付方面的挑战对于实现赛莱科克西布扩大临床效用至关重要.
- 切莱科西布的药物重新定位是药物发现和开发的宝贵策略.
相关概念视频
Targets for Drug Action: Overview
6.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.4K
Prescription, Nonprescription and Orphan Drugs
765
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
765
Drug Discovery: Overview
8.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.1K
Structure-Activity Relationships and Drug Design
769
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
769
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
173
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
173
Drug Clearance: Overview
116
Drug elimination refers to drug removal from the body, either through urine or bile, by the kidneys or liver, respectively. A pharmacokinetic parameter, drug clearance, measures the efficiency of drug removal from the bloodstream within a specific time frame. It is calculated as the rate at which a drug is eliminated from plasma divided by the drug's concentration in plasma.
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination, including...
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination, including...
116


